Seed Wealth Management’s GSK GSK Stock Holding History

Seed Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-6,080	Closed	-$319K	–	88
2026 Q2	$319K	Hold	6,080	–	–	0.2%	72
2026 Q1	$336K	Hold	6,080	–	–	0.23%	64
2025 Q4	$298K	Hold	6,080	–	–	0.21%	76
2025 Q3	$262K	Sell	6,080 -1,020	-14%	-$39.8K	0.18%	90
2025 Q2	$273K	Sell	7,100 -420	-6%	-$16K	0.2%	118
2025 Q1	$291K	Hold	7,520	–	–	0.24%	107
2024 Q4	$254K	Hold	7,520	–	–	0.21%	119
2024 Q3	$307K	Hold	7,520	–	–	0.25%	103
2024 Q2	$290K	Buy	7,520 +420	+6%	+$17.7K	0.25%	100
2024 Q1	$301K	Sell	7,100 -120	-2%	-$4.95K	0.29%	89
2023 Q4	$271K	Hold	7,220	–	–	0.27%	96
2023 Q3	$262K	Hold	7,220	–	–	0.29%	92
2023 Q2	$257K	Hold	7,220	–	–	0.27%	96
2023 Q1	$257K	Hold	7,220	–	–	0.29%	89
2022 Q4	$254K	Buy	+7,220	New	+$240K	0.29%	87

Other funds holding GSK

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Stockman Wealth Management Billings, Montana $960M AUM 19.88% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Seed Wealth Management's GSK Position: Q3 2026 in Review

Seed Wealth Management sold out of GSK (GSK) in Q3 2026, closing a stake of 6,080 shares — an estimated $319K sold.

Seed Wealth Management first reported a position in GSK in Q4 2022 and held it in 15 quarters. The position peaked at $336K in Q1 2026. 348 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Seed Wealth Management reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
Seed Wealth Management sold 6,080 GSK shares in Q3 2026, an estimated $319K.
Seed Wealth Management first reported a position in GSK in Q4 2022 and held it in 15 quarters.
Seed Wealth Management's GSK position peaked at $336K in Q1 2026.
348 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Seed Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.